Every round, fund close and exit we can source, with the article it was reported in and what it actually said.
Australian biotech Currus Biologics has won US regulatory clearance to begin human testing of its lead cancer therapy, CUR-001, combining an antibody platform with CAR T cells for solid tumours.
An independent archive guide cataloguing Jony Ive's design work after Apple through his studio LoveFrom, covering typefaces, emblems, books and product collaborations with clients including Moncler, Linn and Balmuda.
AI medical scribe firm Heidi Health, backed by Blackbird Ventures, is adding autonomous assistants that handle administrative work for doctors, demoing them at a customer event as it challenges entrenched healthcare software vendors.
Interview with Eclipse Ingredients' chief executive on commercialising human lactoferrin through precision fermentation, beginning with cosmetics, plus its distributor agreements and partnerships for manufacturing scale-up.
Queensland battery firm RedEarth Energy Storage has entered voluntary administration, leaving backers including Perennial Partners and Thorney Technologies facing losses after once being valued at $100 million.
Weekly roundup recording a dozen raises and acquisitions, Firmus's scheduled float, a new $50m venture fund, a founder share sale, grant winners, an accelerator intake, and an AI agent's government breach.
Also DealStreetAsia·Dealroom·This Week in Australian Startups·AFR Technology·AFR Technology·Startup Daily·AFR Technology·AFR Technology·ABC News Technology·iTnews
Laundry service launches a customer booking app built on its TimeBoss platform, recalling a 2025 investment raise that funded its tech team, with a British launch planned for early 2027.
West African gold explorer Aurum Resources reported standout drilling results at Boundiali, days after locking in A$52.5 million from institutional investors.
Also The Age Business
Defence Trailblazer funds emissions-reduction projects with Electric Motor Power, Ocius Technology and Praxis, and profiles renewable-technology ventures from its Entrepreneurial Foundations for Defence program.
OnDeck Australia has hired Chris McCall as its inaugural Chief Credit Officer, bringing credit and lending experience from Citizens Bank and other major lenders; he reports to Chief Risk Officer Nicholas Brown.
Dealroom reports Sydney investment house Ellerston Capital plans to buy at least a 12% stake in travel platform Luxury Escapes at a $525 million valuation, with board representation and an expected two-to-three-year exit.
Melbourne biotech Kinoxis completed a $6.75 million round with new backer MainSequence and won a $2.5 million government-funded CUREator+ grant for dementia and pain drug development; MainSequence's Elaine Stead joins the board.
Also Startup Daily·Startup Daily·Dealroom·This Week in Australian Startups·Dynamic Business
Elixinol has agreed an all-share takeover of supplement subscription platform Vitable at a $2.5 million headline value plus earn-out, while shareholder Ben McHarg commits a convertible note; the piece also recaps Vitable's earlier raises.
Taronga Group's RealTechX arm has chosen twelve startups from Australia and abroad for its 2026 Asset Impact program, pairing them with institutional real asset owners.
Morgan Stanley research values AI chip rental firm Firmus at up to $128 billion ahead of its planned IPO next month; four banks will manage the float.
Counter-drone technology firm DroneShield has opened an Adelaide R&D hub, growing its national engineering footprint; South Australia's defence industries minister marked the occasion.
Long-serving Financial Review editor James Chessell departs Nine to edit Joe Aston's new venture Rampart, which has recently banked $2.3 million from five backers; Cosima Marriner steps up to lead the masthead.
Seven Australian health startups receive equity-free grants totalling $15.6 million in the second CUREator+ round for dementia research, backed by the Medical Research Future Fund, spanning gene editing, medicines and diagnostic tools.
A new precision-medicine company formed by Perth's Syngenis Labs, a research institute and two scientists has bought Gene S, maker of the Rosa pharmacogenomics tool; no price was disclosed.
Everlab, a preventative health firm, has tapped agency Outside In to shape its brand and debut campaign, due in October; the piece also cites its $65 million Series A.
Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.
Florida auditor A-LIGN has acquired AssurePoint, gaining IRAP assessment capability and a path into Australian government work; it is the buyer's second purchase this month after Pathfynder.
The renewable energy agency grants Equans Solar & Storage $25 million for Lightspeed, a three-year program trialling up to ten technologies to cut the cost of building and running large-scale solar farms.
Quickli has released Fact Find, a tool automating mortgage broker client intake, document handling and loan scenario generation, alongside mobile and document-analysis updates to its Jiffi AI and Doc Handler products.
Heidi, an Australian clinical AI firm, has banked new funding of US$340m, anchored by a Blackbird-led Series C, to move past scribing into AI agents that handle healthcare tasks under clinician oversight.
Significant Ventures is raising a fourth fund targeting $50 million, with $18 million committed so far from the Snow and Hindmarsh families and CDC founder Greg Boorer.
Profile of Denteric, a biotech developing GPV381, an injectable therapy targeting gum bacteria implicated in Alzheimer's disease; the team is seeking backers to fund its first study in patients.
Brisbane clean-tech firm Graphene Manufacturing Group is issuing shares to a lone private backer for about US$10 million to lift graphene and battery output, with completion due about 23 September.
Sydney biotech Promethean BioPharma has launched an OnMarket crowdfunding round to fund manufacturing, trials and its push for non-prescription status of its CBD pain tablet in Australia.
Heidi raised US$100m in a Blackbird-led Series C plus US$240m in customer-acquisition finance from General Catalyst, reaching a $1.26 billion valuation as Australia's fourth billion-dollar startup of the year.
Also Dealroom·Cut Through Venture·Startup Daily·This Week in Australian Startups·Dynamic Business·This Week in Australian Startups·Mirage News·This Week in Australian Startups·Forbes Australia
Waste platform Jerrara Environmental has taken investment from Direct Capital and MADAUS Capital Partners, the second deal from Direct Capital's $525m fund raised in April 2025.
Airtree Ventures' new Frontier residency offers chosen tech founders $250,000 on SAFE terms plus provider credits; the piece argues a tight peer group beats capital, with lessons for small firms.
Sydney fintech OpenDebt, which applies AI agents to debt recovery, has secured $2 million in pre-seed backing from Blackbird and Antler to grow its team and explore US partnerships.
Also Australian FinTech·Business News Australia·This Week in Australian Startups·Dynamic Business
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Amber, an Australian home battery automation company, has secured a Series E round led by Morgan Stanley's 1GT climate fund, with earlier backers taking part, to support local growth and European expansion.
Beaten Zone Venture Partners led a US$25 million Series B in HEO Robotics, which images other spacecraft, with the NRFC contributing $10 million; the piece also recalls earlier Series A and seed rounds.
Also Forbes Australia·Forbes Australia·Cut Through Venture·Startup Daily·Space Connect·This Week in Australian Startups·Dynamic Business
Brisbane weather-technology startup SkySight has won a £718,586 award from UK research agency ARIA to build stratospheric weather forecasting and flight-planning tools for high-altitude pseudo-satellites, delivered through its UK subsidiary.
Also Dealroom
Energy retailer Amber has closed an oversubscribed $78.5 million round led by Morgan Stanley's 1GT fund, with existing backers participating, to add vehicle-to-grid capability and expand into Europe.
Also Business News Australia·Dealroom·Forbes Australia·Cut Through Venture·Startup Daily·This Week in Australian Startups·Dynamic Business
Melbourne's Telix Pharmaceuticals will merge with German radioisotope maker ITM in a deal worth as much as $3.3 billion, keeping about 76 per cent ownership with existing Telix shareholders once completed.
Also Biotech Dispatch
Listed investor Scalare Partners has taken an undisclosed early-stage stake in Sydney AI scent startup Auric, which has opened a lab at Tank Stream Labs after earlier backing from Antler and Sputnik ATX.
Australian biotech Nyrada has banked US$7.76 million through a share placement managed by Bell Potter, with proceeds going to its clinical pipeline, including the Phase IIa trial of Xolatryp in heart attack patients.
Australian-listed Telix is buying German radioisotope supplier ITM in a $1.65 billion deal with contingent milestone payments, creating an end-to-end radiopharmaceutical business.
Microsoft partner Engage Squared takes an undisclosed growth investment from Alceon to build AI capability and expand across APAC, while promoting co-founder Alastair Cashen and Claudia Piscitelli to bigger roles.
Taronga Group names twelve global startups for its 2026 Asset Impact innovation program, covering power, advanced materials and operations, working with corporate partners including Dexus and Frasers Property.
UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.
RentBetter, a platform letting landlords manage rentals without agents, has secured $5m from VC firm EVP; industry and tenant advocates question whether renters will see the savings.
Also SMH Business·Startup Daily·This Week in Australian Startups
Dealroom reports CSIRO lifting its stake in Main Sequence's early-stage Atmosphere vehicle fourfold to US$12.9 million, money earmarked for a fourth fund the firm has yet to raise.